PLx Pharma Inc. (PLXP)

$ 8.79
+0.01 (+0.11%)
Strong Buy
Symbol PLXP
Price $ 8.79
Beta 4.558
Volume Avg. 0.44M
Market Cap 0.242B
Shares () -
52 Week Range 5.01-21.5
1y Target Est -
DCF Unlevered PLXP DCF ->
DCF Levered PLXP LDCF ->
ROE -128.48% Strong Sell
ROA -62.80% Strong Sell
Operating Margin -
Debt / Equity 95.78% Buy
P/E -
P/B 5.04 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest PLXP news


Mr. David Luci
Healthcare
Drug Manufacturers—Specialty & Generic
Nasdaq Capital Market

PLx Pharma, Inc. is a late-stage specialty pharmaceutical company, which engages in the development and commercialization of technology platform for approved drugs. The company is headquartered in Sparta, New Jersey and currently employs 11 full-time employees. The firm is a late stage specialty pharmaceutical company focusing on commercializing its lead products: Aspertec 325 mg and Aspertec 81 mg (Aspertec). The Company’s products and technology includes PLxGuard delivery system, Aspertec 325 mg, PL1100/PL1200 Ibuprofen. PLxGuard delivery system uses surface acting lipids, such as phospholipids and free fatty acids, to modify the physiochemical properties of various drugs to selectively release these drugs to targeted portions of the GI tract. The Company’s lead product Aspertec 325 mg is a liquid-fill aspirin capsule for prevention of cardiovascular disease. Through PLxGuard delivery system the Company creates a lipid-based formulation of ibuprofen, PL1200 Ibuprofen Capsules, 200 mg.